Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92886279 | 9288627 | 9 | F | 201305 | 20160829 | 20130514 | 20160901 | EXP | PHHY2013LB047712 | NOVARTIS | 68.17 | YR | F | Y | 0.00000 | 20160901 | CN | COUNTRY NOT SPECIFIED | LB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 92886279 | 9288627 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 600 MG, QD | U | 22068 | 600 | MG | CAPSULE | QD | |||||
| 92886279 | 9288627 | 2 | C | GALVUS MET | METFORMIN HYDROCHLORIDEVILDAGLIPTIN | 1 | Oral | 1 DF, Q12H | U | 0 | 1 | DF | TABLET | Q12H | |||||
| 92886279 | 9288627 | 3 | C | FLUDEX | INDAPAMIDE | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | TABLET | QD | |||||
| 92886279 | 9288627 | 4 | C | AERUS | 2 | Oral | 1 DF, QD | U | 0 | 1 | DF | TABLET | QD | ||||||
| 92886279 | 9288627 | 5 | C | XYZAL | LEVOCETIRIZINE DIHYDROCHLORIDE | 1 | Oral | 1 DF, QD | U | 0 | 1 | DF | TABLET | QD | |||||
| 92886279 | 9288627 | 6 | C | REGULAN | 2 | Oral | 1 DF, PRN (SOS) | U | 0 | 1 | DF | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 92886279 | 9288627 | 1 | Chronic myeloid leukaemia |
| 92886279 | 9288627 | 2 | Product used for unknown indication |
| 92886279 | 9288627 | 3 | Product used for unknown indication |
| 92886279 | 9288627 | 4 | Product used for unknown indication |
| 92886279 | 9288627 | 5 | Product used for unknown indication |
| 92886279 | 9288627 | 6 | Product used for unknown indication |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 92886279 | 9288627 | Alopecia | |
| 92886279 | 9288627 | Dry skin | |
| 92886279 | 9288627 | Headache | |
| 92886279 | 9288627 | Hyperglycaemia | |
| 92886279 | 9288627 | Hypersensitivity | |
| 92886279 | 9288627 | Influenza | |
| 92886279 | 9288627 | Ocular hyperaemia | |
| 92886279 | 9288627 | Pruritus | |
| 92886279 | 9288627 | Rash | |
| 92886279 | 9288627 | Skin burning sensation | |
| 92886279 | 9288627 | Skin disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 92886279 | 9288627 | 1 | 201210 | 0 | ||
| 92886279 | 9288627 | 2 | 2004 | 0 | ||
| 92886279 | 9288627 | 3 | 1990 | 0 | ||
| 92886279 | 9288627 | 4 | 201210 | 0 | ||
| 92886279 | 9288627 | 5 | 201212 | 0 |